<DOC>
	<DOCNO>NCT01328392</DOCNO>
	<brief_summary>Although laryno-pharyngeal reflux ( LPR ) gastroesophageal reflux disease ( GERD ) differ symptoms treatment , diagnosed standard 24-hour pH monitoring system measure liquid reflux esophagus . The investigator evaluate new 24-hour pharyngeal pH monitoring system Restech measure acid exposure airway use specifically LPR diagnosis . The purpose study determine whether Restech device effective standard pH monitor predict response proton pump inhibitor ( PPI ) acid suppression therapy use Dexlansoprazole patient symptoms and/or manifestation LPR .</brief_summary>
	<brief_title>Evaluating Treatment Response Laryngo-Pharyngeal Reflux</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Laryngopharyngeal Reflux</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<criteria>Age 18 year old Have clinical diagnosis LPR Able willing provide consent History previous antireflux operation procedure History pharyngeal laryngeal surgery History larngeal hypolaryngeal neoplasm Allergy significant adverse reaction PPI Patient PPI therapy within 4 week prior enrollment A cumulative history PPI therapy equal great 3 month History noncompliance medication study protocol Enrolled another clinical trial use investigational medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>LPR</keyword>
	<keyword>GERD</keyword>
</DOC>